The Efficacy and Safety of Intrapancreatic Bile Duct Resection Applied in Type I of Congenital Bile Duct Dilation: A Multicenter Control Cohort Study
- PMID: 40794433
- PMCID: PMC12513035
- DOI: 10.1097/SLA.0000000000006898
The Efficacy and Safety of Intrapancreatic Bile Duct Resection Applied in Type I of Congenital Bile Duct Dilation: A Multicenter Control Cohort Study
Abstract
Objective: To compare the efficacy and safety of radical extrahepatic cyst excision (REC), which includes the intrapancreatic bile duct (IPBD), and subtotal extrahepatic cyst excision (SEC), which preserves the IPBD, in treating Todani type I congenital bile duct dilation with IPBD involvement (I-IPBD).
Background: The application of REC and SEC in I-IPBD remains debated.
Methods: The multicenter study recruited I-IPBDs who underwent REC or SEC from 5 centers between 2006 and 2024. The primary endpoint was occurrence of long-term complications, including recurrent cholangitis, pancreatitis, and IPBD stones. The secondary outcomes included readmission, reoperation, life quality assessed by Mayo score, carcinogenesis, and perioperative complications categorized as overall, severe, pancreas-related, and severe pancreas-related.
Results: Three hundred fifty-five I-IPBDs were included and divided into the REC group (175 cases) and SEC (180 cases) from 722 type I congenital bile duct dilations. The REC group demonstrated better long-term complication-free survival compared with SEC group (log-rank P < 0.001; hazard ratio = 0.08, 95% CI: 0.04-0.15, P < 0.001). The REC group had lower rates of readmission, reoperation, and carcinogenesis, and achieved a superior Mayo score ( P < 0.05). No significant differences were observed between the REC and SEC groups in overall perioperative complications, severe perioperative complications, and severe pancreas-related perioperative complications ( P > 0.05). Furthermore, subgroup analysis by age demonstrated similar trends in primary and secondary outcomes compared with the overall analysis.
Conclusions: REC was an effective and safe surgical approach for I-IPBD compared with SEC, thus it should be recommended routinely for these patients.
Keywords: congenital bile duct dilation; intrapancreatic bile duct; long-term outcome; perioperative complication; radical resection.
Copyright © 2025 The Author(s). Published by Wolters Kluwer Health, Inc.
Conflict of interest statement
The authors report no conflicts of interest.
Figures
References
-
- Lee SE, Jang JY, Lee YJ, et al. Choledochal cyst and associated malignant tumors in adults: a multicenter survey in South Korea. Arch Surg. 2011;146:1178–1184. - PubMed
-
- Ishibashi H, Shimada M, Kamisawa T, et al. Japanese clinical practice guidelines for congenital biliary dilatation. J Hepatobiliary Pancreat Sci. 2017;24:1–16. - PubMed
-
- Soares KC, Kim Y, Spolverato G, et al. Presentation and clinical outcomes of choledochal cysts in children and adults: a multi-institutional analysis. JAMA Surg. 2015;150:577–584. - PubMed
-
- Stringer MD. Wide hilar hepaticojejunostomy: the optimum method of reconstruction after choledochal cyst excision. Pediatr Surg Int. 2007;23:529–532. - PubMed
Publication types
MeSH terms
Grants and funding
- TUCR10820241000/Tsinghua University School of Clinical Medicine Clinical Research Program
- TUCR10820241004/Tsinghua University School of Clinical Medicine Clinical Research Program
- BJPSTP-2024-23/Beijing Physician Scientist Training Project
- No. 10001020123/Tsinghua University Initiative Scientific Research Program of Precision Medicine
- No. 2022TS014/Tsinghua University Initiative Scientific Research Program of Precision Medicine
LinkOut - more resources
Full Text Sources
